Ronald Blue Trust, Inc. Genmab A/S Transaction History
Ronald Blue Trust, Inc.
- $7.7 Billion
- Q4 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Genmab A/S stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 2,747 shares of GMAB stock, worth $54,088. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,747
Previous 5,757
52.28%
Holding current value
$54,088
Previous $120,000
52.5%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding GMAB
# of Institutions
230Shares Held
52.1MCall Options Held
10.2KPut Options Held
25.5K-
Alliancebernstein L.P. New York, NY14.9MShares$294 Million0.11% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$100 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA4.42MShares$87.1 Million0.02% of portfolio
-
Harding Loevner LP Bridgewater, NJ3.07MShares$60.4 Million0.44% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.79MShares$35.2 Million0.07% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $13B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...